various effects of omega 3 and omega 3 plus vitamin e supplementations on serum glucose level and insulin resistance in patients with coronary artery disease
Authors
abstract
background: omega 3 and vitamin e are two critical nutrients which include beneficial effects in coronary artery disease (cad). the aim of this study was to assess the effects of omega 3 alone supplementation or in combination with vitamin e on serum glucose and lipid levels and insulin resistance in cad patients. methods: participants of this clinical trial included 60 male patients with cad who selected from tehran heart center in tehran, iran in 2014. they received 4 g/day omega 3 plus 400 iu/day vitamin e (oe), 4 g/day omega 3 with vitamin e placebo (op), or omega 3 and vitamin e placebo (pp) for two months. serum glucose, lipids and insulin were assessed and homa-ir was calculated before and after the trial and effects of these nutrients on the highlighted parameters were compared within the study groups. results: serum glucose level increased significantly in op group ( p =0.004), but not in oe group. oe and op groups showed a significant decrease in fasting serum tg ( p =0.020 and p =0.001, respectively). serum insulin and homa-ir decreased significantly in oe group ( p =0.044 and p =0.039, respectively) but did not change significantly in op group. conclusion: although, omega 3 supplementation may include adverse effects on serum glucose level, co-administration of omega 3 and vitamin e can beneficially decrease serum insulin and insulin resistance in cad patients.
similar resources
Various Effects of Omega 3 and Omega 3 Plus Vitamin E Supplementations on Serum Glucose Level and Insulin Resistance in Patients with Coronary Artery Disease
BACKGROUND Omega 3 and vitamin E are two critical nutrients which include beneficial effects in coronary artery disease (CAD). The aim of this study was to assess the effects of omega 3 alone supplementation or in combination with vitamin E on serum glucose and lipid levels and insulin resistance in CAD patients. METHODS Participants of this clinical trial included 60 male patients with CAD w...
full textChanges in Serum Levels of FABP4 and HsCRP after Administration of Omega-3 Fatty Acids Separately or + Vitamin E in Patients with Coronary Artery Disease
Background and purpose: Inflammatory markers of A-FABP and HsCRP play an important role in progression of cardiovascular disease. Anti-inflammatory and anti-platelet aggregation effects of omega-3 fatty acids are known. The aim of this study was to investigate the effects of omega-3 and omega-3+ vitamin E supplements on serum levels of these inflammatory markers. Materials and methods: This d...
full textSupplementation with omega-3 plus vitamin E and zinc plus vitamin C on metabolic syndrome components in postmenopausal women with type 2 diabetes
Background: The aim of this study was to find the influence of supplementation with omega-3 plus vitamin E and vitamin C plus zinc on metabolic syndrome components. Methods: In a double-blind controlled clinical trial, 75 diabetic postmenopausal women were randomly assigned to one of the three therapeutic groups of daily supplementation of 1.8g omega-3 plus 40...
full textOmega-3 fatty acids in atherosclerosis and coronary artery disease
Omega-3 polyunsaturated fatty acids have emerged as possible protective factors associated with a decreased risk for myocardial infarction in populations with a high marine food intake, which may relate to effects on lipid metabolism, thrombosis and inflammation. Omega-3 fatty acids decrease triglyceride levels and also compete as substrates for enzymes involved in the biosynthesis of lipid med...
full textProtective effects of omega-3, atorvastatin, vitamin E and vitamin C against doxorubicin-induced cardiotoxicity in rats: a comparison study
Introduction: The stress-oxidative is involved in doxorubicin (DOX)-induced cardiotoxicity. Due to the potential and previous reported for antioxidant properties of atorvastatin, omega-3, vitamin E and vitamin C, their efficacy to prevention of DOX-induced cardiotoxicity was investigated in this study. Methods: Fifty-six male rats were divided into 8 groups which received omega-3, atorvastati...
full textOmega-3 and serum homocysteine level in hemodialysis patients.
Cardiovascular disease is a leading cause of death in end-stage renal disease patients. One of the well-known independent risk factors is hyperhomocysteinemia. The prevalence of hyperhomocysteinemia is more than 90% in hemodialysis patients.1,2 There are studies that have shown folate and vitamin B6 can decrease the level of homocysteine. However, the effect of these supplements for secondary p...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of public healthجلد ۴۵، شماره ۱۱، صفحات ۱۴۶۵-۱۴۷۲
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023